Home > > > Report Detail

Global Covid-19 Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 28-Sep-2022
No. of pages: 99
Inquire Before Buying

A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.

The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.

The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Covid-19 Vaccine market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Covid-19 Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Covid-19 Vaccine.

The Covid-19 Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Covid-19 Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Covid-19 Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Moderna

- CanSino Biologicals

- Inovio Pharmaceuticals

- Shenzhen Geno-Immune Medical Institute

- GlaxoSmithKine

- Pfizer

- Johnson&Johnson

- Heat Biologics

- Sanofi

Product Type Insights

Global markets are presented by Covid-19 Vaccine type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Covid-19 Vaccine are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

COVID-19 Vaccine Segment by Type

- DNA

- Non-replicating Viral Vector

- Protein Subunit

- RNA

- Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Covid-19 Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Covid-19 Vaccine market.

COVID-19 Vaccine Segment by Application

- Adults

- Children

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Covid-19 Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Covid-19 Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Covid-19 Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Covid-19 Vaccine industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Covid-19 Vaccine.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Global Covid-19 Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Covid-19 Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Covid-19 Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 Market by Application
1.3.1 Global Covid-19 Vaccine Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Covid-19 Vaccine Market Size Estimates and Forecasts
2.2 Covid-19 Vaccine Market Size by Region: 2022 Versus 2028
2.2.1 Global Covid-19 Vaccine Revenue by Region: 2017-2022
2.2.2 Global Covid-19 Vaccine Revenue Forecast by Region (2023-2028)
2.2.3 Global Covid-19 Vaccine Revenue Market Share by Region (2017-2028)
3 Global Covid-19 Vaccine by Company
3.1 Global Covid-19 Vaccine Revenue by Company (2017-2022)
3.2 Global Covid-19 Vaccine Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Covid-19 Vaccine Companies around the World: Ranking by Revenue
3.3.2 Global Covid-19 Vaccine Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Covid-19 Vaccine Companies Headquarters & Product Type
3.4.1 Covid-19 Vaccine Companies Headquarters
3.4.2 Global Covid-19 Vaccine Companies Product & Service
3.4.3 Date of International Companies Enter into Covid-19 Vaccine Market
3.5 Global Covid-19 Vaccine Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Moderna
4.1.1 Moderna Corporation Information
4.1.2 Moderna Description, Business Overview
4.1.3 Moderna Covid-19 Vaccine Products Offered
4.1.4 Moderna Covid-19 Vaccine Revenue and Gross Margin (2017-2022)
4.1.5 Moderna Covid-19 Vaccine Revenue by Product in 2021
4.1.6 Moderna Covid-19 Vaccine Revenue by Application in 2021
4.1.7 Moderna Covid-19 Vaccine Revenue by Geographic Area in 2021
4.1.8 Moderna Recent Developments
4.2 CanSino Biologicals
4.2.1 CanSino Biologicals Corporation Information
4.2.2 CanSino Biologicals Description, Business Overview
4.2.3 CanSino Biologicals Covid-19 Vaccine Products Offered
4.2.4 CanSino Biologicals Covid-19 Vaccine Revenue and Gross Margin (2017-2022)
4.2.5 CanSino Biologicals Covid-19 Vaccine Revenue by Product in 2021
4.2.6 CanSino Biologicals Covid-19 Vaccine Revenue by Application in 2021
4.2.7 CanSino Biologicals Covid-19 Vaccine Revenue by Geographic Area in 2021
4.2.8 CanSino Biologicals Recent Developments
4.3 Inovio Pharmaceuticals
4.3.1 Inovio Pharmaceuticals Corporation Information
4.3.2 Inovio Pharmaceuticals Description, Business Overview
4.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Products Offered
4.3.4 Inovio Pharmaceuticals Covid-19 Vaccine Revenue and Gross Margin (2017-2022)
4.3.5 Inovio Pharmaceuticals Covid-19 Vaccine Revenue by Product in 2021
4.3.6 Inovio Pharmaceuticals Covid-19 Vaccine Revenue by Application in 2021
4.3.7 Inovio Pharmaceuticals Covid-19 Vaccine Revenue by Geographic Area in 2021
4.3.8 Inovio Pharmaceuticals Recent Developments
4.4 Shenzhen Geno-Immune Medical Institute
4.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
4.4.2 Shenzhen Geno-Immune Medical Institute Description, Business Overview
4.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Products Offered
4.4.4 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue and Gross Margin (2017-2022)
4.4.5 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue by Product in 2021
4.4.6 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue by Application in 2021
4.4.7 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue by Geographic Area in 2021
4.4.8 Shenzhen Geno-Immune Medical Institute Recent Developments
4.5 GlaxoSmithKine
4.5.1 GlaxoSmithKine Corporation Information
4.5.2 GlaxoSmithKine Description, Business Overview
4.5.3 GlaxoSmithKine Covid-19 Vaccine Products Offered
4.5.4 GlaxoSmithKine Covid-19 Vaccine Revenue and Gross Margin (2017-2022)
4.5.5 GlaxoSmithKine Covid-19 Vaccine Revenue by Product in 2021
4.5.6 GlaxoSmithKine Covid-19 Vaccine Revenue by Application in 2021
4.5.7 GlaxoSmithKine Covid-19 Vaccine Revenue by Geographic Area in 2021
4.5.8 GlaxoSmithKine Recent Developments
4.6 Pfizer
4.6.1 Pfizer Corporation Information
4.6.2 Pfizer Description, Business Overview
4.6.3 Pfizer Covid-19 Vaccine Products Offered
4.6.4 Pfizer Covid-19 Vaccine Revenue and Gross Margin (2017-2022)
4.6.5 Pfizer Covid-19 Vaccine Revenue by Product in 2021
4.6.6 Pfizer Covid-19 Vaccine Revenue by Application in 2021
4.6.7 Pfizer Covid-19 Vaccine Revenue by Geographic Area in 2021
4.6.8 Pfizer Recent Development
4.7 Johnson?Johnson
4.7.1 Johnson?Johnson Corporation Information
4.7.2 Johnson?Johnson Description, Business Overview
4.7.3 Johnson?Johnson Covid-19 Vaccine Products Offered
4.7.4 Johnson?Johnson Covid-19 Vaccine Revenue and Gross Margin (2017-2022)
4.7.5 Johnson?Johnson Covid-19 Vaccine Revenue by Product in 2021
4.7.6 Johnson?Johnson Covid-19 Vaccine Revenue by Application in 2021
4.7.7 Johnson?Johnson Covid-19 Vaccine Revenue by Geographic Area in 2021
4.7.8 Johnson?Johnson Recent Development
4.8 Heat Biologics
4.8.1 Heat Biologics Corporation Information
4.8.2 Heat Biologics Description, Business Overview
4.8.3 Heat Biologics Covid-19 Vaccine Products Offered
4.8.4 Heat Biologics Covid-19 Vaccine Revenue and Gross Margin (2017-2022)
4.8.5 Heat Biologics Covid-19 Vaccine Revenue by Product in 2021
4.8.6 Heat Biologics Covid-19 Vaccine Revenue by Application in 2021
4.8.7 Heat Biologics Covid-19 Vaccine Revenue by Geographic Area in 2021
4.8.8 Heat Biologics Recent Development
4.9 Sanofi
4.9.1 Sanofi Corporation Information
4.9.2 Sanofi Description, Business Overview
4.9.3 Sanofi Covid-19 Vaccine Products Offered
4.9.4 Sanofi Covid-19 Vaccine Revenue and Gross Margin (2017-2022)
4.9.5 Sanofi Covid-19 Vaccine Revenue by Product in 2021
4.9.6 Sanofi Covid-19 Vaccine Revenue by Application in 2021
4.9.7 Sanofi Covid-19 Vaccine Revenue by Geographic Area in 2021
4.9.8 Sanofi Recent Development
5 Breakdown Data by Type
5.1 Global Covid-19 Vaccine Revenue by Type (2017-2022)
5.2 Global Covid-19 Vaccine Revenue Forecast by Type (2023-2028)
5.3 Covid-19 Vaccine Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Covid-19 Vaccine Revenue by Application (2017-2022)
6.2 Global Covid-19 Vaccine Revenue Forecast by Application (2023-2028)
6.3 Covid-19 Vaccine Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Covid-19 Vaccine Market Size YoY Growth 2017-2028
7.2 North America Covid-19 Vaccine Market Facts & Figures by Country (2017-2028)
7.3 North America Covid-19 Vaccine Revenue by Type (2017-2022)
7.4 North America Covid-19 Vaccine Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Vaccine Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Covid-19 Vaccine Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Covid-19 Vaccine Revenue by Type (2017-2022)
8.4 Asia-Pacific Covid-19 Vaccine Revenue by Application (2017-2022)
9 Europe
9.1 Europe Covid-19 Vaccine Market Size YoY Growth 2017-2028
9.2 Europe Covid-19 Vaccine Market Facts & Figures by Country (2017-2028)
9.3 Europe Covid-19 Vaccine Revenue by Type (2017-2022)
9.4 Europe Covid-19 Vaccine Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Covid-19 Vaccine Market Size YoY Growth 2017-2028
10.2 Latin America Covid-19 Vaccine Market Facts & Figures by Country (2017-2028)
10.3 Latin America Covid-19 Vaccine Revenue by Type (2017-2022)
10.4 Latin America Covid-19 Vaccine Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Covid-19 Vaccine Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Covid-19 Vaccine Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Covid-19 Vaccine Revenue by Type (2017-2022)
11.4 Middle East and Africa Covid-19 Vaccine Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Covid-19 Vaccine Supply Chain Analysis
12.2 Covid-19 Vaccine Key Raw Materials and Upstream Suppliers
12.3 Covid-19 Vaccine Clients Analysis
12.4 Covid-19 Vaccine Sales Channel and Sales Model Analysis
12.4.1 Covid-19 Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Covid-19 Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Covid-19 Vaccine Distributors
13 Market Dynamics
13.1 Covid-19 Vaccine Industry Trends
13.2 Covid-19 Vaccine Market Drivers
13.3 Covid-19 Vaccine Market Challenges
13.4 Covid-19 Vaccine Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Covid-19 Vaccine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of DNA
Table 3. Major Companies of Non-replicating Viral Vector
Table 4. Major Companies of Protein Subunit
Table 5. Major Companies of RNA
Table 6. Major Companies of Others
Table 7. Global Covid-19 Vaccine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Covid-19 Vaccine Market Size by Region (US$ Million): 2022 VS 2028
Table 9. Global Covid-19 Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Covid-19 Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 11. Covid-19 Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 12. Covid-19 Vaccine Revenue Share by Company (2017-2022)
Table 13. Ranking of Global Top Covid-19 Vaccine Players by Revenue (US$ Million) in 2021
Table 14. Global Covid-19 Vaccine Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 15. Global Covid-19 Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Covid-19 Vaccine as of 2021)
Table 16. Global Covid-19 Vaccine Companies Headquarters
Table 17. Global Covid-19 Vaccine Companies Product & Service
Table 18. Date of International Companies Enter into Covid-19 Vaccine Market
Table 19. Global Covid-19 Vaccine Mergers & Acquisitions, Expansion Plans
Table 20. Moderna Corporation Information
Table 21. Moderna Description and Business Overview
Table 22. Moderna Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 23. Moderna Covid-19 Vaccine Product
Table 24. Moderna Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Product in 2021
Table 25. Moderna Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Application in 2021
Table 26. Moderna Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2021
Table 27. Moderna Recent Development
Table 28. CanSino Biologicals Corporation Information
Table 29. CanSino Biologicals Description and Business Overview
Table 30. CanSino Biologicals Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 31. CanSino Biologicals Covid-19 Vaccine Product
Table 32. CanSino Biologicals Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Product in 2021
Table 33. CanSino Biologicals Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Application in 2021
Table 34. CanSino Biologicals Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2021
Table 35. CanSino Biologicals Recent Development
Table 36. Inovio Pharmaceuticals Corporation Information
Table 37. Inovio Pharmaceuticals Description and Business Overview
Table 38. Inovio Pharmaceuticals Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 39. Inovio Pharmaceuticals Covid-19 Vaccine Product
Table 40. Inovio Pharmaceuticals Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Product in 2021
Table 41. Inovio Pharmaceuticals Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Application in 2021
Table 42. Inovio Pharmaceuticals Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2021
Table 43. Inovio Pharmaceuticals Recent Development
Table 44. Shenzhen Geno-Immune Medical Institute Corporation Information
Table 45. Shenzhen Geno-Immune Medical Institute Description and Business Overview
Table 46. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 47. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product
Table 48. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Product in 2021
Table 49. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Application in 2021
Table 50. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2021
Table 51. Shenzhen Geno-Immune Medical Institute Recent Development
Table 52. GlaxoSmithKine Corporation Information
Table 53. GlaxoSmithKine Description and Business Overview
Table 54. GlaxoSmithKine Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 55. GlaxoSmithKine Covid-19 Vaccine Product
Table 56. GlaxoSmithKine Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Product in 2021
Table 57. GlaxoSmithKine Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Application in 2021
Table 58. GlaxoSmithKine Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2021
Table 59. GlaxoSmithKine Recent Development
Table 60. Pfizer Corporation Information
Table 61. Pfizer Description and Business Overview
Table 62. Pfizer Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 63. Pfizer Covid-19 Vaccine Product
Table 64. Pfizer Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Product in 2021
Table 65. Pfizer Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Application in 2021
Table 66. Pfizer Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2021
Table 67. Johnson?Johnson Corporation Information
Table 68. Johnson?Johnson Description and Business Overview
Table 69. Johnson?Johnson Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 70. Johnson?Johnson Covid-19 Vaccine Product
Table 71. Johnson?Johnson Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Product in 2021
Table 72. Johnson?Johnson Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Application in 2021
Table 73. Johnson?Johnson Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2021
Table 74. Heat Biologics Corporation Information
Table 75. Heat Biologics Description and Business Overview
Table 76. Heat Biologics Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 77. Heat Biologics Covid-19 Vaccine Product
Table 78. Heat Biologics Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Product in 2021
Table 79. Heat Biologics Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Application in 2021
Table 80. Heat Biologics Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2021
Table 81. Sanofi Corporation Information
Table 82. Sanofi Description and Business Overview
Table 83. Sanofi Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 84. Sanofi Covid-19 Vaccine Product
Table 85. Sanofi Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Product in 2021
Table 86. Sanofi Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Application in 2021
Table 87. Sanofi Covid-19 Vaccine Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2021
Table 88. Global Covid-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 89. Global Covid-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 90. Global Covid-19 Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 91. North America Covid-19 Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. North America Covid-19 Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. North America Covid-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 94. North America Covid-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia-Pacific Covid-19 Vaccine Revenue by Region (2017-2028) & (US$ Million)
Table 96. Asia-Pacific Covid-19 Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 97. Asia-Pacific Covid-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 98. Asia-Pacific Covid-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 99. Europe Covid-19 Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 100. Europe Covid-19 Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 101. Europe Covid-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 102. Europe Covid-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 103. Latin America Covid-19 Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Latin America Covid-19 Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Latin America Covid-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Covid-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Covid-19 Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Covid-19 Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Covid-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 110. Middle East and Africa Covid-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 111. Covid-19 Vaccine Key Raw Materials, Industry Status and Trend
Table 112. Covid-19 Vaccine Key Raw Materials and Upstream Suppliers
Table 113. Covid-19 Vaccine Clients Status and Trend
Table 114. Covid-19 Vaccine Typical Clients
Table 115. Covid-19 Vaccine Distributors
Table 116. Covid-19 Vaccine Market Trends
Table 117. Covid-19 Vaccine Market Drivers
Table 118. Covid-19 Vaccine Market Challenges
Table 119. Covid-19 Vaccine Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Covid-19 Vaccine Product Picture
Figure 2. Global Covid-19 Vaccine Revenue Market Share by Type in 2021 & 2028
Figure 3. DNA Product Picture
Figure 4. Non-replicating Viral Vector Product Picture
Figure 5. Protein Subunit Product Picture
Figure 6. RNA Product Picture
Figure 7. Others Product Picture
Figure 8. Global Covid-19 Vaccine Revenue Market Share by Application in 2021 & 2028
Figure 9. Adults
Figure 10. Children
Figure 11. Covid-19 Vaccine Report Years Considered
Figure 12. Global Covid-19 Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Covid-19 Vaccine Market Size 2017-2028 (US$ Million)
Figure 14. Global Covid-19 Vaccine Market Size Market Share by Region: 2022 Versus 2028
Figure 15. Global Covid-19 Vaccine Revenue Market Share by Region (2017-2028)
Figure 16. Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Covid-19 Vaccine Revenue Market Share Forecast by Type (2017-2028)
Figure 18. Global Covid-19 Vaccine Revenue Market Share Forecast by Application (2017-2028)
Figure 19. North America Covid-19 Vaccine Revenue 2017-2028 (US$ Million)
Figure 20. North America Covid-19 Vaccine Revenue Market Share by Type (2017-2022)
Figure 21. North America Covid-19 Vaccine Revenue Market Share by Application (2017-2022)
Figure 22. Asia-Pacific Covid-19 Vaccine Revenue 2017-2028 (US$ Million)
Figure 23. Asia-Pacific Covid-19 Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. Asia-Pacific Covid-19 Vaccine Revenue Market Share by Type (2017-2022)
Figure 25. Asia-Pacific Covid-19 Vaccine Revenue Market Share by Application (2017-2022)
Figure 26. Europe Covid-19 Vaccine Revenue Growth Rate 2017-2028 (US$ Million)
Figure 27. Europe Covid-19 Vaccine Revenue Market Share by Country (2017-2028)
Figure 28. Europe Covid-19 Vaccine Revenue Market Share by Type (2017-2022)
Figure 29. Europe Covid-19 Vaccine Revenue Market Share by Application (2017-2022)
Figure 30. Latin America Covid-19 Vaccine Revenue Growth Rate 2017-2028 (US$ Million)
Figure 31. Latin America Covid-19 Vaccine Revenue Market Share by Country (2017-2022)
Figure 32. Latin America Covid-19 Vaccine Revenue Market Share by Type (2017-2022)
Figure 33. Latin America Covid-19 Vaccine Revenue Market Share by Application (2017-2022)
Figure 34. Middle East and Africa Covid-19 Vaccine Revenue Growth Rate 2017-2028 (US$ Million)
Figure 35. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Country (2017-2028)
Figure 36. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Type (2017-2022)
Figure 37. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Application (2017-2022)
Figure 38. Covid-19 Vaccine Supply Chain (Upstream and Downstream Market)
Figure 39. Global Production Market Share of Covid-19 Vaccine Raw Materials by Region in 2021
Figure 40. Covid-19 Vaccine Distribution Channels
Figure 41. Global Covid-19 Vaccine Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 42. Global Covid-19 Vaccine Percentage 2017-2028: Online Sales VS Offline Sales
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs